文献速递皮肤肿瘤

厚度>1 mm的原发性皮肤黑色素瘤中消退的预后影响

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
PubMed 文献 · J Am Acad Dermatol · 2018-11-14

该多中心回顾性研究纳入1998-2015年4个意大利黑色素瘤协作组中心诊断的1182例Breslow厚度>1 mm原发性皮肤黑色素瘤患者,其中954例(304例伴消退、650例无消退)纳入分析。消退组前哨淋巴结活检阳性比例低于无消退组(24.4% vs 31.6%,卡方检验P=0.0368);多因素分析未发现消退与无病间期或黑色素瘤特异性生存相关。

要点

  • 消退组前哨淋巴结活检阳性比例低于无消退组(24.4% vs 31.6%,P=0.0368)。
  • 多因素分析未发现消退与无病间期相关(HR 1.11,95%CI 0.85-1.46;P=0.4509)。
  • 多因素分析未发现消退与黑色素瘤特异性生存相关(HR 1.05,95%CI 0.77-1.44;P=0.7600)。

核心结论

  • 在本系列中,消退不是Breslow厚度>1 mm原发性皮肤黑色素瘤患者的独立预后因素,但与较低的前哨淋巴结活检阳性发生率相关。

研究设计与样本

  • 研究纳入意大利黑色素瘤协作组4个中心诊断的患者,采用按中心分层的单因素和多因素Cox比例风险模型分析消退对无病间期和黑色素瘤特异性生存的影响。
  • 1998-2015年诊断的1182例Breslow厚度>1 mm原发性皮肤黑色素瘤患者中,954例(304例伴消退、650例无消退)纳入分析。

主要发现

  • 消退组前哨淋巴结活检阳性患者比例低于无消退组(24.4% vs 31.6%,卡方检验P=0.0368)。
  • 多因素分析未发现消退与无病间期相关(风险比1.11,95%置信区间0.85-1.46;P=0.4509)。
  • 多因素分析未发现消退与黑色素瘤特异性生存相关(风险比1.05,95%置信区间0.77-1.44;P=0.7600)。

局限性

  • 回顾性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of histologic regression on sentinel lymph node biopsy (SLNB) status and on clinical outcome is uncertain. OBJECTIVE: To investigate whether and to what extent regression <75% is able to predict SLNB status and clinical outcome of patients with melanoma >1-mm thick. METHODS: The study included patients with diagnoses given at 4 centers of the Italian Melanoma Intergroup. Univariate and multivariate Cox proportional hazard models stratified by center were used to analyze the effect of regression on disease-free interval and melanoma-specific survival. RESULTS: Out of 1182 patients given primary cutaneous melanoma diagnoses during 1998-2015 with a Breslow thickness >1 mm, 954 (304 with and 650 without regression) were included in the analysis. The proportion of patients with a positive SLNB was lower in patients with regression than without (24.4% vs 31.6%, chi-squared test P = .0368). At multivariate analysis, no association was detected between regression and disease-free interval (hazard ratio 1.11, 95% confidence interval 0.85-1.46; P = .4509) or melanoma-specific survival (hazard ratio 1.05, 95% confidence interval 0.77-1.44; P = .7600). LIMITATION: Retrospective analysis. CONCLUSION: In our series, regression was not an independent prognostic factor in primary cutaneous melanoma patients with Breslow thickness >1 mm whereas it was associated with a lower incidence of SLNB positivity.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ribero S, Galli F, Osella-Abate S, et al. Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness. J Am Acad Dermatol. 2018. PMID: 30447951. doi:10.1016/j.jaad.2018.06.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。